AlphaLens
Research
财报Equal-weightTP $202.00005月7日 · Morgan Stanley

Arm Holdings plc: Growing Confidence of an Agentic Future

ARM
中文EN⚠ quality lint: see notes

Arm Holdings plc: Agentic AI Drives CPU Demand Surge, but TSMC Supply Caps Near-Term Growth

Core Conclusion

Arm’s FY26 results confirm a structurally accelerating growth story led by Cloud AI royalties and a new CPU chip for agentic workloads. However, near-term upside is constrained by TSMC’s advanced-node wafer availability, limiting the company’s ability to fully capture a projected $2bn+ chip opportunity across FY27-28. We maintain Equal-weight with a raised price target of $202, reflecting higher IP multiples, but the stock trades above that level at $237.

What the Market May Underestimate

  1. CPU demand velocity – Six weeks post-launch, the new AGI chip already shows strong enterprise interest. This is not a slow ramp; early commercial deployments and power-efficiency positioning for agentic AI suggest demand could materialize faster than consensus models assume.
  2. Cloud AI royalty compounding – Management expects Cloud AI royalties to double year-over-year in FY26 and potentially again in FY27. If sustained, this re-acceleration would materially lift consolidated royalty growth well above the ~20% headline guide.
  3. Supply improvement timeline – TSMC is expected to increase 3nm availability into CY26-27. While allocation uncertainty remains, incremental capacity could unlock a material revenue upside beyond current forecasts.

Evidence Chain

Financial Results & Guidance

  • Q4 FY26 revenue $1.49bn (beat vs. $1.47bn consensus), EPS $0.60 (beat vs. $0.58). Licensing rose 29% YoY; royalties grew 11% YoY to $671m (4% below street).
  • Q1 FY27 guidance: revenue ~$1.26bn midpoint (~20% YoY), EPS ~$0.40 (8% above street). Management frames full-year royalty and licensing growth at ~20% each, with licensing skewed 60% H2 vs. 40% H1.
  • Opex guided to ~$760m in Q1, rising 4-5% sequentially, implying opex growth roughly in line with top-line. Scope for incremental margin expansion.

CPU Demand Signal

  • Management reported demand building quickly since the CPU chip announcement, particularly from large enterprises. Early deployments and power-efficiency design for agentic AI are key drivers.
  • The $2bn+ chip revenue target across FY27-28 was doubled vs. prior guidance. Practical constraint is access to TSMC advanced wafers.

Core IP Business Trajectory

  • Cloud AI royalties already >2x YoY in Q4. Management expects similar doubling in FY26 and FY27, supported by hyperscaler custom CPU adoption and DPU/SmartNIC penetration.
  • CPU TAM for orchestration: incremental demand shows up through higher core counts per system, not mechanically higher CPU:GPU ratios. Avoids double-counting between core count and chip ratio.

Investment Implication

  • The mapping between agentic session growth, token generation, and CPU core requirements remains uncertain, making TAM estimates sensitive to assumptions. Focus on core count expansion as a proxy.

Key Divergences & Risks

Supply Constraint – TSMC’s 3nm capacity allocation between Arm and other high-volume customers is unknown. Near-term shortages could limit Arm’s ability to serve the $2bn+ chip opportunity. Management’s conservative guidance until supply visibility improves is prudent.

Royalty Softness – Q4 royalty miss ($671m vs. street $698m) may be transitory (e.g., handset DRAM disruption) or signal a mix shift. Cloud AI royalty strength must offset any handset weakness.

Licensing Durability – Strong licensing this quarter (including next-gen CSS wins) may not sustain at 29% YoY growth, especially given H2-weighted typical seasonality.

Competition & Litigation – Open-source RISC-V encroachment and outstanding litigation (Qualcomm) pose downside risks. If chip business fails to reach scale, bear case valuation drops to $65.

Valuation & Trade Implications

We value Arm on SOTP: IP business at 50x EV/EBIT (upper historical range, justified by Cloud AI emergence), chip business at 20x EV/EBIT (discount to global chip peers but reflecting growth potential). Discounting FY29 at 11% WACC yields a price target of $202 (from $191). Current share price $237.30 implies 14.9% downside. We raise chip revenue estimates modestly to $113m in FY27 (from $83m) and $1.46bn in FY28 (from $1.18bn), but supply visibility limits confidence.

Key monitorables: TSMC wafer allocation announcements, Cloud AI royalty re-acceleration, licensing conversion in H2, and any updates on the AGI chip commercial availability.

Related (同 ticker)